Scale-up of Electrospinning: Market Overview of Products and Devices for Pharmaceutical and Biomedical Purposes
Recently, the electrospinning (ES) process has been extensively studied due to its potential applications in various fields, particularly pharmaceutical and biomedical purposes. The production rate using typical ES technology is usually around 0.01–1 g/h, which is lower than pharmaceutical industry...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-02-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/13/2/286 |
| _version_ | 1797395646486937600 |
|---|---|
| author | Safaa Omer László Forgách Romána Zelkó István Sebe |
| author_facet | Safaa Omer László Forgách Romána Zelkó István Sebe |
| author_sort | Safaa Omer |
| collection | DOAJ |
| description | Recently, the electrospinning (ES) process has been extensively studied due to its potential applications in various fields, particularly pharmaceutical and biomedical purposes. The production rate using typical ES technology is usually around 0.01–1 g/h, which is lower than pharmaceutical industry production requirements. Therefore, different companies have worked to develop electrospinning equipment, technological solutions, and electrospun materials into large-scale production. Different approaches have been explored to scale-up the production mainly by increasing the nanofiber jet through multiple needles, free-surface technologies, and hybrid methods that use an additional energy source. Among them, needleless and centrifugal methods have gained the most attention and applications. Besides, the production rate reached (450 g/h in some cases) makes these methods feasible in the pharmaceutical industry. The present study overviews and compares the most recent ES approaches successfully developed for nanofibers’ large-scale production and accompanying challenges with some examples of applied approaches in drug delivery systems. Besides, various types of commercial products and devices released to the markets have been mentioned. |
| first_indexed | 2024-03-09T00:38:31Z |
| format | Article |
| id | doaj.art-71859b6a291341f2be51174796f7dab3 |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-09T00:38:31Z |
| publishDate | 2021-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-71859b6a291341f2be51174796f7dab32023-12-11T17:58:37ZengMDPI AGPharmaceutics1999-49232021-02-0113228610.3390/pharmaceutics13020286Scale-up of Electrospinning: Market Overview of Products and Devices for Pharmaceutical and Biomedical PurposesSafaa Omer0László Forgách1Romána Zelkó2István Sebe3University Pharmacy Department of Pharmacy Administration, Semmelweis University, Hőgyes Endre Street 7-9, 1092 Budapest, HungaryDepartment of Biophysics and Radiation Biology, Semmelweis University, Tűzoltó Street 37-47, 1094 Budapest, HungaryUniversity Pharmacy Department of Pharmacy Administration, Semmelweis University, Hőgyes Endre Street 7-9, 1092 Budapest, HungaryUniversity Pharmacy Department of Pharmacy Administration, Semmelweis University, Hőgyes Endre Street 7-9, 1092 Budapest, HungaryRecently, the electrospinning (ES) process has been extensively studied due to its potential applications in various fields, particularly pharmaceutical and biomedical purposes. The production rate using typical ES technology is usually around 0.01–1 g/h, which is lower than pharmaceutical industry production requirements. Therefore, different companies have worked to develop electrospinning equipment, technological solutions, and electrospun materials into large-scale production. Different approaches have been explored to scale-up the production mainly by increasing the nanofiber jet through multiple needles, free-surface technologies, and hybrid methods that use an additional energy source. Among them, needleless and centrifugal methods have gained the most attention and applications. Besides, the production rate reached (450 g/h in some cases) makes these methods feasible in the pharmaceutical industry. The present study overviews and compares the most recent ES approaches successfully developed for nanofibers’ large-scale production and accompanying challenges with some examples of applied approaches in drug delivery systems. Besides, various types of commercial products and devices released to the markets have been mentioned.https://www.mdpi.com/1999-4923/13/2/286electrospinning (ES)nanofibers (NFs)scale-uppharmaceutical industry |
| spellingShingle | Safaa Omer László Forgách Romána Zelkó István Sebe Scale-up of Electrospinning: Market Overview of Products and Devices for Pharmaceutical and Biomedical Purposes Pharmaceutics electrospinning (ES) nanofibers (NFs) scale-up pharmaceutical industry |
| title | Scale-up of Electrospinning: Market Overview of Products and Devices for Pharmaceutical and Biomedical Purposes |
| title_full | Scale-up of Electrospinning: Market Overview of Products and Devices for Pharmaceutical and Biomedical Purposes |
| title_fullStr | Scale-up of Electrospinning: Market Overview of Products and Devices for Pharmaceutical and Biomedical Purposes |
| title_full_unstemmed | Scale-up of Electrospinning: Market Overview of Products and Devices for Pharmaceutical and Biomedical Purposes |
| title_short | Scale-up of Electrospinning: Market Overview of Products and Devices for Pharmaceutical and Biomedical Purposes |
| title_sort | scale up of electrospinning market overview of products and devices for pharmaceutical and biomedical purposes |
| topic | electrospinning (ES) nanofibers (NFs) scale-up pharmaceutical industry |
| url | https://www.mdpi.com/1999-4923/13/2/286 |
| work_keys_str_mv | AT safaaomer scaleupofelectrospinningmarketoverviewofproductsanddevicesforpharmaceuticalandbiomedicalpurposes AT laszloforgach scaleupofelectrospinningmarketoverviewofproductsanddevicesforpharmaceuticalandbiomedicalpurposes AT romanazelko scaleupofelectrospinningmarketoverviewofproductsanddevicesforpharmaceuticalandbiomedicalpurposes AT istvansebe scaleupofelectrospinningmarketoverviewofproductsanddevicesforpharmaceuticalandbiomedicalpurposes |